Friday 6 November 2026
Export BCPC’s income statement to Excel — free account
Balchem Corporation
BCPC Basic Materials Specialty Chemicals
Balchem Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.0 billion, up 8.75% from fiscal 2024.
- Revenue
- +8.63%
- EPS
- +17.7%
- Free cash flow
- +14.4%
- Total debt
- −16.7%
Quarter to September 2026, against a year earlier
179.33
3.25
−1.78%
Follow BCPC
Alert me
Target Price Range
Analyst price targets
Free accountTen years at a glance Fiscal years to December
| Ten-year view | Analyst estimates Powerpack | |||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Group | Line | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM Sep ’26 | Trend | 10 yrs | 2026e | 2027e | 2028e | Next 3/yr |
| Income, $m | ||||||||||||||||||
| Income, $m | Revenue | 553 | 595 | 644 | 644 | 704 | 799 | 942 | 922 | 954 | 1,037 | 1,109 | +7.2% | 1,132 | 1,199 | 1,264 | +6.8% | |
| Gross margin, % | 32.69 | 31.78 | 31.73 | 32.84 | 31.82 | 30.43 | 29.76 | 32.75 | 35.25 | 35.74 | 36.46 | +3.0 pt | ||||||
| EBT | 83 | 88 | 99 | 96 | 106 | 125 | 134 | 137 | 166 | 199 | 220 | +10.2% | ||||||
| EBT margin, % | 14.99 | 14.88 | 15.38 | 14.99 | 15.12 | 15.67 | 14.19 | 14.88 | 17.45 | 19.19 | 19.87 | +4.2 pt | ||||||
| Net income | 56 | 90 | 79 | 80 | 85 | 96 | 105 | 109 | 128 | 155 | 171 | +12.0% | ||||||
| Per share, $ | ||||||||||||||||||
| Per share, $ | Revenue | 17.55 | 18.68 | 20.06 | 20.03 | 21.87 | 24.80 | 29.43 | 28.73 | 29.50 | 32.15 | 34.99 | +7.0% | |||||
| Earnings | 1.75 | 2.79 | 2.42 | 2.45 | 2.60 | 2.94 | 3.25 | 3.35 | 3.93 | 4.75 | 5.31 | +11.7% | ||||||
| Cash flow | 3.41 | 3.47 | 3.70 | 3.87 | 4.68 | 4.98 | 4.33 | 5.72 | 5.63 | 6.71 | 7.06 | +7.8% | ||||||
| Capex | (0.76) | (0.88) | (0.61) | (0.88) | (1.05) | (1.15) | (1.55) | (1.12) | (1.09) | (1.34) | (1.44) | +6.5% | ||||||
| Free cash flow | 2.65 | 2.59 | 3.08 | 2.99 | 3.63 | 3.83 | 2.77 | 4.60 | 4.54 | 5.37 | 5.62 | +8.2% | ||||||
| Book value | 16.53 | 19.38 | 21.55 | 23.14 | 25.74 | 27.22 | 29.30 | 32.83 | 35.57 | 38.97 | 41.86 | +10.0% | ||||||
| Shares, m | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | 32 | +0.3% | ||||||
| Valuation, × | ||||||||||||||||||
| Valuation, × | P/E | 47.58 | 29.23 | 32.24 | 41.31 | 44.32 | 57.15 | 37.47 | 43.64 | 41.48 | 32.29 | 33.77 | 40.7 | |||||
| P/S | 4.74 | 4.36 | 3.91 | 5.07 | 5.27 | 6.80 | 4.14 | 5.09 | 5.53 | 4.77 | 5.13 | 5.0 | ||||||
| P/B | 5.04 | 4.21 | 3.64 | 4.39 | 4.48 | 6.19 | 4.16 | 4.45 | 4.58 | 3.94 | 4.28 | 4.5 | ||||||
| EV/Sales | 5.19 | 4.67 | 4.13 | 5.42 | 5.45 | 6.87 | 4.60 | 5.41 | 5.73 | 4.91 | 5.23 | 5.2 | ||||||
| EV/FCF | 34.36 | 33.78 | 26.77 | 36.35 | 32.84 | 44.40 | (21.00) | (33.82) | (36.77) | (41.55) | (49.27) | 7.5 | ||||||
| Cash, $m | ||||||||||||||||||
| Cash, $m | Operating cash flow | 108 | 111 | 119 | 124 | 150 | 161 | 139 | 184 | 182 | 217 | 224 | +8.1% | |||||
| Capex | (24) | (28) | (20) | (28) | (34) | (37) | (50) | (36) | (35) | (43) | (46) | +6.8% | ||||||
| Free cash flow | 84 | 83 | 99 | 96 | 117 | 123 | 89 | 148 | 147 | 173 | 178 | +8.4% | ||||||
| Balance, $m | ||||||||||||||||||
| Balance, $m | Working capital | 87 | 91 | 144 | 163 | 172 | 178 | 196 | 166 | 156 | 189 | 241 | +9.0% | |||||
| Net debt | 249 | 184 | 109 | 191 | 92 | 21 | 403 | 264 | 162 | 112 | 81 | (8.4%) | ||||||
| Shareholders’ equity | 521 | 617 | 692 | 744 | 828 | 877 | 938 | 1,054 | 1,150 | 1,257 | 1,327 | +10.3% | ||||||
| Returns, % | ||||||||||||||||||
| Returns, % | ROA | 6.12 | 9.42 | 8.08 | 7.46 | 7.29 | 8.13 | 7.46 | 6.74 | 8.10 | 9.49 | 10.16 | +3.4 pt | |||||
| ROIC | 7.38 | 7.56 | 8.36 | 6.86 | 7.55 | 8.87 | 6.77 | 7.55 | 8.72 | 9.55 | 10.19 | +2.2 pt | ||||||
| ROE | 11.37 | 15.83 | 12.01 | 11.10 | 10.77 | 11.27 | 11.61 | 10.90 | 11.66 | 12.86 | 13.02 | +1.5 pt | ||||||
| People | ||||||||||||||||||
| People | Employees | 1,060 | 1,165 | 1,135 | 1,424 | 1,342 | 1,317 | 1,340 | 1,302 | 1,361 | 1,352 | — | +2.7% | |||||
| Revenue/emp, $m | 0.52 | 0.51 | 0.57 | 0.45 | 0.52 | 0.61 | 0.70 | 0.71 | 0.70 | 0.77 | — | +4.4% | ||||||
Negative figures in brackets.
estimates
Fiscal years to Dec 2025 · latest quarter Sep 2026 · fundamentals updated 2 Nov 2026
Balchem Corporation vs peers in Specialty Chemicals (Q) = latest quarter vs a year earlier
| Company | Market cap | P/E | Fwd P/E | Revenue growth (Q) | EPS growth (Q) | FCF growth (Q) | Gross margin (Q) | EBIT margin (Q) | Compare |
|---|---|---|---|---|---|---|---|---|---|
| SQM Sociedad Quimica y Minera S.A. | $8.1B | 10.6× | 7.4× | +138.12% (above 0%: growing) | +381.25% (above 0%: growing) | −63.75% (below 0%: shrinking) | 51.05% | 48.62% | Compare |
| AXTA Axalta Coating Systems Ltd. | $7.8B | 23.3× | 18.8× | +1.79% (above 0%: growing) | −12.96% (below 0%: shrinking) | +2.30% (above 0%: growing) | 33.10% | 12.59% | Compare |
| EMN Eastman Chemical Company | $7.5B | 12.0× | 11.5× | +8.31% (above 0%: growing) | +266.44% (above 0%: growing) | −26.42% (below 0%: shrinking) | 22.31% | 12.79% | Compare |
| ESI Element Solutions Inc. | $7.5B | 36.4× | 30.7× | +51.70% (above 0%: growing) | +68.75% (above 0%: growing) | +53.88% (above 0%: growing) | 34.40% | 11.44% | Compare |
| NEU NewMarket Corporation | $6.4B | 14.0× | — (loss-making) | +3.79% (above 0%: growing) | +26.52% (above 0%: growing) | −73.94% (below 0%: shrinking) | 31.03% | 19.95% | Compare |
| BCPC Balchem Corporation | $5.7B | 33.8× | 31.0× | +8.63% (above 0%: growing) | +17.74% (above 0%: growing) | +14.42% (above 0%: growing) | 36.37% | 21.48% | |
| SXT Sensient Technologies Corporation | $5.1B | 30.0× | 28.0× | +10.61% (above 0%: growing) | +31.03% (above 0%: growing) | −90.87% (below 0%: shrinking) | 36.19% | 15.89% | Compare |
| PRM Perimeter Solutions, SA | $4.6B | 102× | 27.1× | +23.59% (above 0%: growing) | n/m | −22.31% (below 0%: shrinking) | 61.14% | 106.82% | Compare |
| AVNT Avient Corporation | $4.2B | 23.1× | 17.6× | +10.50% (above 0%: growing) | +31.78% (above 0%: growing) | +101.69% (above 0%: growing) | 30.50% | 9.27% | Compare |
| Median of peers | $6.9B | 23.2× | 18.8× | +10.56% | +31.78% | −24.36% | 33.75% | 14.34% |
Pay and ownership Proxy statement filed 27 April 2026
Chief executive’s pay
| Year | Total pay | Actually paid | $100 invested |
|---|---|---|---|
| 2025 | 7.89m | 4.92m | 136.68 |
| 2024 | 6.87m | 10.37m | 144.37 |
| 2023 | 5.89m | 10.94m | 131.07 |
| 2022 | 11.95m | 7.98m | 107.02 |
| 2021 | 5.76m | 12.20m | 146.90 |
Ownership
Directors and executive officers, together
1.65%
BlackRock, Inc.
14.59%
The Vanguard Group, Inc.
11.80%
Total pay is as the Summary Compensation Table states it; actually paid revalues the year’s share awards
at its end, as the SEC’s pay-versus-performance rule asks. $100 invested is what $100 in the company’s
shares at the start of the earliest year shown was worth at each year’s end.
Ownership is the proxy’s own table: the directors and officers as a group, and every holder of 5% or more.
Read the proxy statement
Balchem Corporation (BCPC) Latest News
23 Oct
31 Jul
30 Apr
24 Mar
21 Mar
17 Mar
BCPC metrics, ten years each
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score